Stockport, United Kingdom

Andrew Golding

This inventor holds 2 USPTO granted patents. Top assignee: Micromass UK Limited. Active years: 2017-2019.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Andrew Golding: Innovator in Sample Screening Technology

Introduction

Andrew Golding is a notable inventor based in Stockport, GB. He has made significant contributions to the field of sample screening technology, holding a total of 2 patents. His innovative methods have the potential to enhance the efficiency of identifying compounds of interest in various samples.

Latest Patents

Golding's latest patents focus on a method of screening samples for at least one compound of interest. This method involves comparing the ion mobility and at least one further physicochemical property of the ions of a compound of interest to the same properties of candidate ions in the sample. By matching the properties of the compound of interest to those of a candidate ion in the sample, it can be determined whether the sample comprises the compound of interest.

Career Highlights

Andrew Golding is currently associated with Micromass UK Limited, where he applies his expertise in developing innovative screening methods. His work has contributed to advancements in analytical chemistry and has implications for various industries, including pharmaceuticals and environmental science.

Collaborations

Golding has collaborated with notable colleagues such as David Eatough and Jeffrey Goshawk. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Andrew Golding is a distinguished inventor whose work in sample screening technology has led to valuable patents and collaborations. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…